Hyderabad firm delivers anti-swine flu drug

Image
Press Trust of India Hyderabad
Last Updated : Aug 21 2009 | 8:20 PM IST

Hyderabad-based Hetero Drugs, the licensee for the supply of anti-swine flu Oseltamivir (Tamiflu), today delivered 90 lakh capsules of the drug, following an order from the Union government.

The order, finalised urgently yesterday, was for the supply of one crore capsules, Hetero Drugs Director M Srinivasa Reddy told PTI here.

The remaining 10 lakh capsules will be delivered by Monday, he said.

The company keeps an inventory of two crore capsules -- one crore in ready packs and another crore in the form of raw material, Reddy said.

Hetero Drugs will also supply four lakh bottles of Oseltamivir for paediatric use by the end of the month, he said.

The company can manufacture 10 crore capsules a month but can produce 10 crore more per month at its new plant in Visakhapatnam, he added.

Hetero Drugs has the licence from Swiss company Roche to manufacture and supply Oseltamivir in India and many other developing countries.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 21 2009 | 8:20 PM IST

Next Story